Condition: Melanoma Metastatic · Uveal Melanoma, Metastatic · Mucosal Melanoma · Sponsor: Alpha-9 Oncology USA Inc.
The goal of this trial is to see if this investigational drug is safe for adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery. It will also see if this investigational drug can shrink melanoma tumors in the body. The main questions this study aims to answer are: * What are the side effects of this investigational drug? * What is the highest dose of this investigational drug that can be given safely? Participants will: * Take the investigational drug once every 6 weeks, for up to 6 times in total * Visit a doctor's office on a regular basis for checkups and tests
This description comes directly from the study's public registry record.
Sam Vohra · +61 300 131 548 · sam@avionmedical.com.au
Always discuss trial participation with your own doctor first.
| Alfred Health | Melbourne, Victoria, Australia | Recruiting |
| Austin Health | Melbourne, Victoria, Australia | Recruiting |
| Fiona Stanley Hospital | Murdoch, Western Australia, Australia | Not Yet Recruiting |
| GenesisCare Murdoch | Murdoch, Western Australia, Australia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07076550